Nationwide Class Action Lawsuit Filed Against CVS Caremark Over Billing Practices

July 6 2011

Cincinnati, OH: A nationwide consumer fraud class action lawsuit has been filed against CVS Caremark, the largest pharmacy health care provider in the United States and the owners of, for allegedly double-billing its customers for the price of prescription drugs.

The Complaint alleges that CVS’s nationwide billing system double-bills the price of prescription drugs to CVS customers who have a high deductible health plan that is coupled with a health reimbursement account or health savings account (HSA) and who use a prescription drug coupon. CVS’s billing system isn’t equipped to handle this coordination of benefits, and as a result, CVS uniformly double-bills these customers––taking cash from the customer at the time of sale and then later taking cash from their HSA.

The class action lawsuit was filed in state court in Cincinnati on July 5, 2011. It brings class action claims on behalf of all CVS customers who were allegedly double-billed the price of prescription drugs and seeks damages on behalf of those customers estimated to be in the hundreds of thousands across the country.

CVS Caremark Billing Class Action Legal Help

If you or a loved one has suffered damages in this case, please fill in the form to the right and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Reader Comments

Posted by
Karen Brown
CVS charges higher for meds. Caremark stated that they would charge more if I went to another pharmacy. The would honor my coupons. I am diabetic. They honor coupons for their candy and often delay delivery of my meds. I am now at least one week without insulin. I finally transferred my scripts and I will standby my decision.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment: